An Interview with Kevin Winthrop_ Three Questions About COVID 19
Assessment and Treatment of Cardiovascular Risks in Rheumatoid Arthritis
Biologics in RA_ Mechanisms of Delivery Over Mechanisms of Action_ (1)
Cannabinoid Receptor in RA Patients
Impact of Tofacitinib on Skeletal Muscle in RA
No Increased Mortality in Patients with RA Receiving Checkpoint Inhibitors
Non-TNFi b_tsDMARDs vs. TNFi in RA-ILD
Older RA Patients Just Aren't Getting Treated
People with RA and Long COVID Had Worse Pre-COVID RA Symptoms
Reproductive History, HPV Vaccination Among Women with SLE and RA
Teledidactic vs On Campus Training in Musculoskeletal Ultrasound
The SMART Study_ Split Dose Oral Methotrexate
Unravelling the Mechanism of Clots with JAK Inhibitors
Upadacitinib for Pain_ Is That Real_
Will CAR T Cells also treat RA_
EULAR 2024 Daily Podcasts Day1&2
Predicting Palindromic Prognosis
A Step Closer to Identifying Phenotypes of RA ILD
Top 3 Messages About JAK Inhibitor Safety
Pain in RA: Different Drugs for Different Mechanisms
Giant Cell Arteritis and Polymyalgia Rheumatica Update
JAK Inhibitors for New Indications
Top 3 Messages About JAK Inhibitor Safety
Pain in RA: Different Drugs for Different Mechanisms
JAK Inhibitors for New Indications
Potential of Radiomics to Predict TNF Therapy Outcomes in axSpA
Treat to Target Outcomes in Early AxSpA
Does Telemonitoring in SpA Work?
PsA Treatment: is Earlier Better?
JAK Inhibitors for New Indications
Transition from Psoriasis to PsA: Can we Prevent It?
EULAR 2024 Daily Recap - Days 1 & 2
Mechanistic Promise in RA Doesn’t Always Mean Actual Gain
The Role of Psychosocial Determinants in the Management of Rheumatoid Arthritis
Do we need more IL-17 and JAK Inhibitors in Spondyloarthritis?
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive